News & Analysis on Clinical Trial Services & Contract Research And Development
Baxter International says Pfizer supplied the bulk API used in a batch of Heparin linked to two patient deaths in Delaware, US last week, amid concerns of a repeat of last year’s contamination scandal.
Rottendorf Pharma has completed its development and upscaling pilot plant, which will complement its other sites that provide manufacturing and packaging services.
US non-clinical contract research firm Wil Research Laboratories has reduced its 700 strong workforce by 4 per cent, citing a drop in business due to the global economic downturn as the basis for the cuts.
GlaxoSmithKline (GSK) is to take a 16 per cent stake in Aspen in exchange for a manufacturing facility and eight medicines, building on the companies’ relationship and the big pharma’s profile in Africa.
A new $60m (€43m) manufacturing suite is operational at the South Carolina, US plant where Roche makes APIs for some of its leading products, including for its anti-flu drug Tamiflu (oseltamivir).
Sanofi-Aventis has expanded its collaboration with Pilgrims to include its Dagenham, UK facility, which will now be guarded by the security services company.
Cambridge Consultants has developed its ‘connected patient’ technology, which creates a communication network between drug delivery devices and healthcare professionals to increase compliance.